Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000039

Chief Medical Officer sold 7,000 shares at an average $61.85 ($432,935)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-05-15 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 36,877 D
2026-05-15 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 40,377 D
2026-05-15 Sale : show line 3 in the form 10b5-1 −4,800 $61.56 $295,495 35,577 D
2026-05-15 Sale : show line 4 in the form 10b5-1 −2,100 $62.42 $131,088 33,477 D
2026-05-15 Sale : show line 5 in the form 10b5-1 −100 $63.52 $6,352 33,377 D
Open-market sales · 7,000 sh · avg $61.85 · $432,935

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-05-15 Exercise or conversion : show line 6 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 207,563 D
2026-05-15 Exercise or conversion : show line 7 in the form 10b5-1 Employee Warrant (right to buy) −3,500 178,992 D
Loading xslF345X06/form4.xml…